Simlandi (adalimumab-adaz) Injection 80 mg/0.8 mL Prefilled Syringe, Single-Dose, Teva Pharmaceuticals
Simlandi is a biosimilar to Humira (adalimumab) containing 80 mg of adalimumab-adaz in a 0.8 mL prefilled syringe for subcutaneous injection. It is a tumor necrosis factor (TNF) blocker used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. Each syringe is a single-dose, ready-to-use device for self-administration.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Simlandi is a biosimilar to Humira (adalimumab) containing 80 mg of adalimumab-adaz in a 0.8 mL prefilled syringe for subcutaneous injection. It is a tumor necrosis factor (TNF) blocker used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. Each syringe is a single-dose, ready-to-use device for self-administration.
1 vendor
